非小细胞肺癌治疗进展和标准.pptVIP

老年早期NSCLC 首选SABR 同步放化疗是Ⅲ期NSCLC标准治疗 同步放化疗适应症 同步放化疗中的放疗剂量不宜过高66 同步放化疗中化疗剂量个体化 全球放疗进展研讨会 2013.10.18（17-19）GASTRO (global advance symposium of therapeutic radiology and oncology) 来一次北肿，晓全年进展 ASTRO/ESTRO/ASCO/ESMO Pts with pathologically proven, resectable stage IIIA/N2 NSCLC, performance status 0-1, adequate heart, kidney, liver and bone marrow function Randomized 3 cycles of NCT alone (cisplatin 100 mg/m2 and docetaxel 85 mg/m2 d1, q3weeks) NCT + accelerated concomitant boost RT (44 Gy/22 fractions in 3 weeks) J Clin Oncol 31, 2013 (suppl; abstr 7503) 276 PET START试验——PET-CT在III期NSCLC治疗